Theolytics starts a £1M project in collaboration with the University of Sheffield, supported by Innovate UK to develop a novel therapy for multiple myeloma patients ...Middle East

PR Newswire - News
OXFORD, England , June 1, 2022 /PRNewswire/ -- Theolytics is a biotechnology company harnessing viruses to combat disease. The company has been awarded a Biomedical catalyst grant by Innovate UK to progress a novel therapy for multiple myeloma patients. Multiple myeloma is an incurable...

Hence then, the article about theolytics starts a 1m project in collaboration with the university of sheffield supported by innovate uk to develop a novel therapy for multiple myeloma patients was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Theolytics starts a £1M project in collaboration with the University of Sheffield, supported by Innovate UK to develop a novel therapy for multiple myeloma patients )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News